{"id":415921,"date":"2024-10-20T06:07:55","date_gmt":"2024-10-20T06:07:55","guid":{"rendered":"https:\/\/pdfstandards.shop\/product\/uncategorized\/bsi-pd-iso-ts-24560-12022\/"},"modified":"2024-10-26T11:23:43","modified_gmt":"2024-10-26T11:23:43","slug":"bsi-pd-iso-ts-24560-12022","status":"publish","type":"product","link":"https:\/\/pdfstandards.shop\/product\/publishers\/bsi\/bsi-pd-iso-ts-24560-12022\/","title":{"rendered":"BSI PD ISO\/TS 24560-1:2022"},"content":{"rendered":"
PDF Pages<\/th>\n | PDF Title<\/th>\n<\/tr>\n | ||||||
---|---|---|---|---|---|---|---|
2<\/td>\n | National foreword <\/td>\n<\/tr>\n | ||||||
6<\/td>\n | Foreword <\/td>\n<\/tr>\n | ||||||
7<\/td>\n | Introduction <\/td>\n<\/tr>\n | ||||||
9<\/td>\n | 1 Scope 2 Normative references 3 Terms and definitions <\/td>\n<\/tr>\n | ||||||
11<\/td>\n | 4 Principles <\/td>\n<\/tr>\n | ||||||
12<\/td>\n | 5 T2 mapping evaluation in human knee articular cartilage 5.1 Characterization parameters and methods <\/td>\n<\/tr>\n | ||||||
14<\/td>\n | 5.2 T2 value measurement process 5.2.1 Post-processing of imaging 5.2.2 Measurement method <\/td>\n<\/tr>\n | ||||||
15<\/td>\n | 5.2.3 ROIs of regenerative cartilage 5.2.4 ROIs of normal control cartilage <\/td>\n<\/tr>\n | ||||||
16<\/td>\n | 5.3 T2 value evaluation 5.3.1 Purpose of evaluation 5.3.2 In vivo evaluation of regenerative cartilage with T2 value <\/td>\n<\/tr>\n | ||||||
17<\/td>\n | 6 dGEMRIC evaluation in human knee articular cartilage 6.1 Characterization parameters and methods <\/td>\n<\/tr>\n | ||||||
18<\/td>\n | 6.2 T1 value measurement process 6.2.1 Post-processing of imaging <\/td>\n<\/tr>\n | ||||||
19<\/td>\n | 6.2.2 Measurement method 6.2.3 ROIs of regenerative cartilage 6.2.4 ROIs of normal control cartilage <\/td>\n<\/tr>\n | ||||||
20<\/td>\n | 6.3 \u0394R1 value calculation 6.4 \u0394R1 value evaluation 6.4.1 Purpose of evaluation 6.4.2 In vivo evaluation of regenerative cartilage with \u0394R1 values <\/td>\n<\/tr>\n | ||||||
22<\/td>\n | 7 Acceptable standard for MR evaluation 7.1 Requirements for MR equipment 7.2 Requirements for MR parameters 7.3 Requirements for the MR longitudinally evaluation 7.4 Exclusion criteria 8 Limitation <\/td>\n<\/tr>\n | ||||||
24<\/td>\n | Annex A (informative) Example of measurement results <\/td>\n<\/tr>\n | ||||||
34<\/td>\n | Annex B (informative) Introduction of T1\u03c1 MR Imaging technology <\/td>\n<\/tr>\n | ||||||
36<\/td>\n | Bibliography <\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":" Tissue-engineered medical products. MRI evaluation of cartilage – Clinical evaluation of regenerative knee articular cartilage using delayed gadolimium-enhanced MRI of cartilage (dGEMRIC) and T2 mapping<\/b><\/p>\n |